Company research / ATNM
Actinium Pharmaceuticals, Inc. (ATNM)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, Actinium Pharmaceuticals, Inc. reported revenue of $90.0K.
Key ratios (year ended 2025-12-31)
-40274.4%
Operating margin
-37652.2%
Net margin
-432.6%
Return on year-end equity
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.